Indian Pharmacopoeia is the official book of standards for drugs included therein, in terms of the Second Schedule to the Drugs and Cosmetics Act, 1940so as to specify the: Standards of identity, purity and strength for the drugs imported, manufactured for sale, stocked or exhibited for sale or distributed in India.
It is a reference document for various stockholders like enforcement agency, industry, lab, academic institutions etc. Compliance with IP Standards by drug manufacturing industry assures consumers, patients and healthcare professionals of their quality.
As India is the best developer of generic pharmaceuticals and taking the lead in adopting new technologies Therefore there is a need for the sustainable compliance of quality specifications of drugs and pharmaceuticals.
IP ensures the control of the quality of not only the formulations (dosage forms) but also of the active pharmaceutical ingredients (APIs).
Current Issues
Amendments to IP 2007 have been published in IP Addendum 2008. Further amendments are to be taken care of in IP 2009 edition.
Publication of IP 2009 by Dec. 2009 is the immediate priority. Work is in full swing.
159
Drug molecules have been short listed for the IP 2009. The APIs and their formulations monographs are being prepared at the IPC.
Monograph
inclusion/deletion criteria and the Monograph Inclusion Form have been uploaded on the website of the Commission.
It will enable the public to obtain treatment at reasonable cost. It will form an integral part of rational therapeutics as far as teaching institutions are concerned.
Challenges
1. Arrangement, procurement, preparation, evaluation, containerization and distribution of all the IP Reference Substances is still a challenge for the Commission. The Commission has identified the Chemical Reference Substances and impurities RS required on the priority basis and 115 Reference Substances certified by the Commission. The issue of the remaining ones is to be addressed shortly.
2.
. 3.
IPC has the strategy to start pharmacopoeial Education and Training Programme for generating talented human resource. Harmonization: Collaborative efforts needed to bring harmonization/uniformity of Standards. It will reduce wastage of resources and time.
IPC already has tied up with USP. British Pharmacopoeia Commission and EDQM are also keen to have working relations with IPC.